Protection of Trigonelline on Experimental Diabetic Peripheral Neuropathy
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2012, 1-8
Abstract
The mechanisms leading to diabetic peripheral neuropathy are complex and there is no effective drug to treat it. As an active component of several traditional Chinese medicines, trigonelline has beneficial effects on diabetes with hyperlipidemia. The protective effects and the mechanism of trigonelline on diabetic peripheral neuropathy were evaluated in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Rats were divided into four groups at the end of week 2: control, diabetes, diabetes + trigonelline (40 mg/kg), and diabetes + sitagliptin (4 mg/kg). After 48-week treatment, technologies of nerve conduction, cold and hot immersion test, transmission electron microscopy, real-time PCR, and Western blotting were applied. Serum glucose, serum insulin, insulin sensitivity index, lipid parameters, body weight, sciatic nerve conduction velocity, nociception, glucagon-like peptide-1 receptor mRNA and protein, total and phosphorylated p38 mitogen-activated protein kinases protein expression, malonaldehyde content, and superoxide dismutase activity were altered in diabetic rats, and were near control levels treated with trigonelline. Slight micropathological changes existed in sciatic nerve of trigonelline-treated diabetic rats. These findings suggest that trigonelline has beneficial effects for diabetic peripheral neuropathy through glucagon-like peptide-1 receptor/p38 mitogen-activated protein kinases signaling pathway, nerve conduction velocity, antioxidant enzyme activity, improving micropathological changes of sciatic nerve and decreasing lipid peroxidation.Keywords
Funding Information
- National Natural Science Foundation of China (81100597, CSTC 2009BA5012, 2009XQN34)
- Natural Science Foundation Project of Chongqing Science and Technology Commission (81100597, CSTC 2009BA5012, 2009XQN34)
- Natural Science Foundation of Third Military Medical University (81100597, CSTC 2009BA5012, 2009XQN34)
This publication has 52 references indexed in Scilit:
- Bioassay-Guided Isolation of Neuroprotective Compounds fromUncaria rhynchophyllaagainst Beta-Amyloid-Induced NeurotoxicityEvidence-Based Complementary and Alternative Medicine, 2012
- GLP‐1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic miceDiabetes, Obesity and Metabolism, 2011
- Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic ratsBritish Journal of Pharmacology, 2011
- Glucagon‐like peptide 1 receptor stimulation as a means of neuroprotectionBritish Journal of Pharmacology, 2010
- Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasiaMolecular and Cellular Endocrinology, 2009
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and ParkinsonismProceedings of the National Academy of Sciences, 2009
- Chemokines and the pathophysiology of neuropathic painProceedings of the National Academy of Sciences, 2007
- SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathyExperimental Neurology, 2007
- Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathyExperimental Neurology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001